AIM movers: Chariot investee company funding and more delays for Biome Technologies

Yesterday, Blue Star Capital (LON: BLU) said it did not know why the share price was rising. That led to a decline, but it has risen a further 28.6% to 0.0225p today.

Chariot (LON: CHAR) owns 49% of South African electricity trading platform Etana Energy has secured a $100m guarantee finance facility. This could finance $500m of new renewable projects with a generating capacity of 500MW in total. This is the first step in securing financing to develop the business and it provides validation of the business, which could become a highly valuable investment for Chariot. The share price moved up 7.71% to 1.955p.

- Advertisement -

N4 Pharma (LON: N4P) has filed a patent for its oral anti-inflammatory irritable bowel disease product in early pre-clinical development. It uses the Nuvec delivery system. The share price jumped 17.4% to 0.675p.

Fund manager Premier Miton (LON: PMI) increased assets under management by 9% to £10.7bn in the year to September 2024 and the figure rose to £10.9bn by the end of November 2024. Pre-tax profit fell from £5.9m to £3.2m and the total dividend was maintained at 6p/share.  The share price is 10% higher at 60.5p.

Geomab has exercised its option to licence an anti-glycan monoclonal antibody from Scancell Holdings (LON: SCLP). Anti-glycan antibodies with high affinity are difficult to produce. The total deal is worth up to $630m and the upfront payment could be around $5m. Scancell will have enough cash until the end of 2025. The share price increased 5.77% to 13.75p.

FALLERS

- Advertisement -

Biome Technologies (LON: BIOM) says additional problems with large projects relating to bought in parts and assemblies mean they will not be delivered this year. This means 2024 results will be well below the previously downgraded figure. Additional working capital is required and a debt facility is being discussed. John Standen has stepped down from the board. The share price slumped 28.6% to 3.75p.

Clinical diagnostics company Oxford BioDynamics (LON: OBD) says it continues to try to secure funding. There is no guarantee that it will be successful. Cash will be required early in 2025. The share price dived 26.7% to 1.6125p.

New Technology Capital Group has reduced its stake in data processing semiconductor technology developer Ethernity Networks (LON: ENET) to below 3%. This announcement comes when Ethernity Networks is raising £130,000 at 0.133p. This provides working capital. The share price fell 11.4% to 0.14p.

Thor Energy (LON: THR) has appointed Dekel Agri-Vision (LON: DKL) boss Lincoln Moore as a non-executive director. Rowan Harland takes over as company secretary.The office in Adelaide is being closed. The share price declined 10.3% to 0.65p.

Latest News

Subscribe to the UK Investor Magazine email newsletter

Register for our free email newsletter and receive the latest investment news, podcasts, event information and offers.

More Articles Like This